Fifth Third Bancorp’s VanEck Pharmaceutical ETF PPH Stock Holding History

Fifth Third Bancorp’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.2K	Sell	112 -1,043	-90%	-$108K	﹤0.01%	3690
2026 Q1	$120K	Buy	+1,155	New	+$123K	﹤0.01%	2820
2019 Q3	–	Sell	-200	Closed	-$12K	–	2312
2019 Q2	$12K	Buy	+200	New	+$11.6K	﹤0.01%	1787
2017 Q1	–	Sell	-145	Closed	-$8K	–	2199
2016 Q4	$8K	Buy	+145	New	+$7.75K	﹤0.01%	1850
2015 Q3	–	Sell	-336	Closed	-$24K	–	2982
2015 Q2	$24K	Buy	+336	New	+$24.2K	﹤0.01%	1724

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Fifth Third Bancorp's PPH Position: Q2 2026 in Review

Fifth Third Bancorp reduced its VanEck Pharmaceutical ETF (PPH) stake by 90% in Q2 2026, selling an estimated $108K and leaving 112 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3690.

Fifth Third Bancorp first reported a position in PPH in Q2 2015 and has held it in 5 quarters since. The position peaked at $120K in Q1 2026. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Fifth Third Bancorp held 112 shares of VanEck Pharmaceutical ETF worth $12.2K as of Q2 2026.
Fifth Third Bancorp sold 1,043 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $108K.
VanEck Pharmaceutical ETF made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3690 holding.
Fifth Third Bancorp first reported a position in VanEck Pharmaceutical ETF in Q2 2015 and has held it in 5 quarters since.
Fifth Third Bancorp's VanEck Pharmaceutical ETF position peaked at $120K in Q1 2026.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.